Cargando…
Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis
Zoledronate or denosumab treatment is beneficial for cancer patients with bone metastasis. However, each agent may trigger atypical femoral fractures. Incomplete atypical femoral fractures can be successfully treated with prophylactic intramedullary nailing. On the other hand, intramedullary nailing...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171208/ https://www.ncbi.nlm.nih.gov/pubmed/30402317 http://dx.doi.org/10.1155/2018/7862516 |
_version_ | 1783360750076559360 |
---|---|
author | Tamiya, Hironari Hagizawa, Hiroki Nakai, Takaaki Imura, Yoshinori Tanaka, Takaaki Oshima, Kazuya Ito, Toshikazu Naka, Norifumi Kuratsu, Shigeyuki |
author_facet | Tamiya, Hironari Hagizawa, Hiroki Nakai, Takaaki Imura, Yoshinori Tanaka, Takaaki Oshima, Kazuya Ito, Toshikazu Naka, Norifumi Kuratsu, Shigeyuki |
author_sort | Tamiya, Hironari |
collection | PubMed |
description | Zoledronate or denosumab treatment is beneficial for cancer patients with bone metastasis. However, each agent may trigger atypical femoral fractures. Incomplete atypical femoral fractures can be successfully treated with prophylactic intramedullary nailing. On the other hand, intramedullary nailing for displaced atypical femoral fractures occasionally causes problems with regard to bone healing, resulting in long-term treatment. In cancer patients with poor prognosis who experience atypical femoral fractures, improvement in activities of daily living should be the priority. Thus, we performed endoprosthetic reconstruction for a displaced atypical femoral fracture in a breast cancer patient with poor prognosis to enable walking in the early stage after the operation. Two weeks after the operation, she could successfully walk. The postoperative Musculoskeletal Tumor Society score was 47%, and it had improved to almost the preoperative level before injury (50%). In conclusion, endoprosthetic reconstruction for displaced atypical femoral fractures may be a first-line treatment approach to acquire early postoperative walking ability for improving activities of daily living in cancer patients with poor prognosis. |
format | Online Article Text |
id | pubmed-6171208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-61712082018-11-06 Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis Tamiya, Hironari Hagizawa, Hiroki Nakai, Takaaki Imura, Yoshinori Tanaka, Takaaki Oshima, Kazuya Ito, Toshikazu Naka, Norifumi Kuratsu, Shigeyuki Case Rep Orthop Case Report Zoledronate or denosumab treatment is beneficial for cancer patients with bone metastasis. However, each agent may trigger atypical femoral fractures. Incomplete atypical femoral fractures can be successfully treated with prophylactic intramedullary nailing. On the other hand, intramedullary nailing for displaced atypical femoral fractures occasionally causes problems with regard to bone healing, resulting in long-term treatment. In cancer patients with poor prognosis who experience atypical femoral fractures, improvement in activities of daily living should be the priority. Thus, we performed endoprosthetic reconstruction for a displaced atypical femoral fracture in a breast cancer patient with poor prognosis to enable walking in the early stage after the operation. Two weeks after the operation, she could successfully walk. The postoperative Musculoskeletal Tumor Society score was 47%, and it had improved to almost the preoperative level before injury (50%). In conclusion, endoprosthetic reconstruction for displaced atypical femoral fractures may be a first-line treatment approach to acquire early postoperative walking ability for improving activities of daily living in cancer patients with poor prognosis. Hindawi 2018-09-20 /pmc/articles/PMC6171208/ /pubmed/30402317 http://dx.doi.org/10.1155/2018/7862516 Text en Copyright © 2018 Hironari Tamiya et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Tamiya, Hironari Hagizawa, Hiroki Nakai, Takaaki Imura, Yoshinori Tanaka, Takaaki Oshima, Kazuya Ito, Toshikazu Naka, Norifumi Kuratsu, Shigeyuki Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title | Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title_full | Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title_fullStr | Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title_full_unstemmed | Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title_short | Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis |
title_sort | endoprosthetic reconstruction for a displaced atypical femoral fracture in a cancer patient with poor prognosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171208/ https://www.ncbi.nlm.nih.gov/pubmed/30402317 http://dx.doi.org/10.1155/2018/7862516 |
work_keys_str_mv | AT tamiyahironari endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT hagizawahiroki endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT nakaitakaaki endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT imurayoshinori endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT tanakatakaaki endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT oshimakazuya endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT itotoshikazu endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT nakanorifumi endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis AT kuratsushigeyuki endoprostheticreconstructionforadisplacedatypicalfemoralfractureinacancerpatientwithpoorprognosis |